FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094448293> ?p ?o ?g. }

• W2094448293 endingPage "56" @default.
• W2094448293 startingPage "46" @default.
• W2094448293 abstract "Using an a priori theoretic model of behavior change, factors predicting enrollment in a randomized chemoprevention trial during the first year of recruitment were assessed prospectively.Eligible participants were asked to complete a 90-item semistructured questionnaire after attendance at an informational meeting. Components of the Health Belief Model (including perceived susceptibility, perceived severity, perceived benefits and barriers, cues to action, and health motivation), health status, preventive health behaviors, and social influence were assessed in relation to enrollment.Overall, 331 women attended one of the meetings, and 73% completed a questionnaire; 45% enrolled on the trial and 55% did not. In bivariate analyses, all but one of the perceived barriers were associated negatively with enrollment; however, items assessing perceived susceptibility, perceived severity, and perceived benefits were not. Nonparticipants also were more likely to be over 49 years of age, to be currently or to have been on estrogen replacement therapy, and to have had hot flashes. In logistic regression analysis, not being able to take estrogen replacement therapy was the strongest predictor of nonparticipation (odds ratio [OR], 12.13, 95% confidence interval [CI], 3.63, 40.60). Other factors associated with nonparticipation were concern about side effects of tamoxifen (OR, 5.06; CI, 2.37, 10.80); the possibility of getting a placebo (OR, 7.75; CI, 1.51, 39.67); the costs associated with the trial (OR, 3.21; CI, 1.12, 9.24); and absence of concern that significant others would be reassured if the respondent was taking tamoxifen (OR, 2.58; CI, 1.04, 6.41).These findings support the view that recruitment efforts for chemoprevention trials should address barriers specific to their circumstances. In addition, increasing the support available from personal social networks may enhance recruitment to chemoprevention trials for breast cancer." @default.
• W2094448293 created "2016-06-24" @default.
• W2094448293 creator A5000444179 @default.
• W2094448293 creator A5027033922 @default.
• W2094448293 creator A5038893344 @default.
• W2094448293 creator A5053881786 @default.
• W2094448293 creator A5061711559 @default.
• W2094448293 creator A5084510407 @default.
• W2094448293 date "1995-07-01" @default.
• W2094448293 modified "2023-10-15" @default.
• W2094448293 title "Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment" @default.
• W2094448293 cites W124956636 @default.
• W2094448293 cites W1932330315 @default.
• W2094448293 cites W1963664028 @default.
• W2094448293 cites W1965918055 @default.
• W2094448293 cites W1966623655 @default.
• W2094448293 cites W1969574381 @default.
• W2094448293 cites W1989446922 @default.
• W2094448293 cites W1994163278 @default.
• W2094448293 cites W1998930452 @default.
• W2094448293 cites W2024551000 @default.
• W2094448293 cites W2028965295 @default.
• W2094448293 cites W2032481011 @default.
• W2094448293 cites W2043701651 @default.
• W2094448293 cites W2045329615 @default.
• W2094448293 cites W2049504786 @default.
• W2094448293 cites W2050327724 @default.
• W2094448293 cites W2050862338 @default.
• W2094448293 cites W2058950320 @default.
• W2094448293 cites W2072963577 @default.
• W2094448293 cites W2088991761 @default.
• W2094448293 cites W2089160644 @default.
• W2094448293 cites W2090569056 @default.
• W2094448293 cites W2110869155 @default.
• W2094448293 cites W2113433866 @default.
• W2094448293 cites W2122682324 @default.
• W2094448293 cites W2134740567 @default.
• W2094448293 cites W2151617981 @default.
• W2094448293 cites W2155903022 @default.
• W2094448293 cites W2158216255 @default.
• W2094448293 cites W2165664908 @default.
• W2094448293 cites W2313594197 @default.
• W2094448293 cites W2328384548 @default.
• W2094448293 cites W2412734670 @default.
• W2094448293 cites W4246588623 @default.
• W2094448293 cites W4252823809 @default.
• W2094448293 cites W4253039673 @default.
• W2094448293 cites W4296216085 @default.
• W2094448293 doi "https://doi.org/10.1002/1097-0142(19950701)76:1<46::aid-cncr2820760107>3.0.co;2-b" @default.
• W2094448293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8630876" @default.
• W2094448293 hasPublicationYear "1995" @default.
• W2094448293 type Work @default.
• W2094448293 sameAs 2094448293 @default.
• W2094448293 citedByCount "55" @default.
• W2094448293 countsByYear W20944482932012 @default.
• W2094448293 countsByYear W20944482932014 @default.
• W2094448293 countsByYear W20944482932016 @default.
• W2094448293 countsByYear W20944482932017 @default.
• W2094448293 countsByYear W20944482932018 @default.
• W2094448293 countsByYear W20944482932019 @default.
• W2094448293 countsByYear W20944482932021 @default.
• W2094448293 countsByYear W20944482932022 @default.
• W2094448293 crossrefType "journal-article" @default.
• W2094448293 hasAuthorship W2094448293A5000444179 @default.
• W2094448293 hasAuthorship W2094448293A5027033922 @default.
• W2094448293 hasAuthorship W2094448293A5038893344 @default.
• W2094448293 hasAuthorship W2094448293A5053881786 @default.
• W2094448293 hasAuthorship W2094448293A5061711559 @default.
• W2094448293 hasAuthorship W2094448293A5084510407 @default.
• W2094448293 hasBestOaLocation W20944482931 @default.
• W2094448293 hasConcept C121608353 @default.
• W2094448293 hasConcept C126322002 @default.
• W2094448293 hasConcept C138816342 @default.
• W2094448293 hasConcept C144024400 @default.
• W2094448293 hasConcept C149923435 @default.
• W2094448293 hasConcept C151956035 @default.
• W2094448293 hasConcept C156957248 @default.
• W2094448293 hasConcept C159110408 @default.
• W2094448293 hasConcept C1602351 @default.
• W2094448293 hasConcept C185618831 @default.
• W2094448293 hasConcept C44249647 @default.
• W2094448293 hasConcept C512399662 @default.
• W2094448293 hasConcept C530470458 @default.
• W2094448293 hasConcept C71924100 @default.
• W2094448293 hasConceptScore W2094448293C121608353 @default.
• W2094448293 hasConceptScore W2094448293C126322002 @default.
• W2094448293 hasConceptScore W2094448293C138816342 @default.
• W2094448293 hasConceptScore W2094448293C144024400 @default.
• W2094448293 hasConceptScore W2094448293C149923435 @default.
• W2094448293 hasConceptScore W2094448293C151956035 @default.
• W2094448293 hasConceptScore W2094448293C156957248 @default.
• W2094448293 hasConceptScore W2094448293C159110408 @default.
• W2094448293 hasConceptScore W2094448293C1602351 @default.
• W2094448293 hasConceptScore W2094448293C185618831 @default.
• W2094448293 hasConceptScore W2094448293C44249647 @default.
• W2094448293 hasConceptScore W2094448293C512399662 @default.
• W2094448293 hasConceptScore W2094448293C530470458 @default.
• W2094448293 hasConceptScore W2094448293C71924100 @default.

• next